Chaoyuan Liu Min Lu Yang Yang Xiang Wang Fang Ma Xianling Liu
10.3389/fonc.2022.961539
Front Oncol
2022 Aug 8;12:961539.
braf v600e mutation lung cancer major pathologic response neoadjuvant targeted therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/36003777/
Case Reports
PMC9393753
36003777
Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutation
2022